Advanced Cancers With Egfr Exon20 Insertions Mutations clinical trials

Explore recruiting advanced cancers with egfr exon20 insertions mutations clinical trials.

Recruiting advanced cancers with egfr exon20 insertions mutations studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Cancers With Egfr Exon20 Insertions Mutations trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1/2 Study of BLU-451 in Advanced Cancers with EGFR exon20 Insertion Mutations

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Advanced Cancers With Egfr Exon20 Insertions Mutations trials by city

Advanced Cancers With Egfr Exon20 Insertions Mutations in Toronto Advanced Cancers With Egfr Exon20 Insertions Mutations in Vancouver Advanced Cancers With Egfr Exon20 Insertions Mutations in Montreal Advanced Cancers With Egfr Exon20 Insertions Mutations in Calgary Advanced Cancers With Egfr Exon20 Insertions Mutations in Edmonton Advanced Cancers With Egfr Exon20 Insertions Mutations in Ottawa Advanced Cancers With Egfr Exon20 Insertions Mutations in Winnipeg Advanced Cancers With Egfr Exon20 Insertions Mutations in Quebec City Advanced Cancers With Egfr Exon20 Insertions Mutations in Hamilton Advanced Cancers With Egfr Exon20 Insertions Mutations in Kitchener Advanced Cancers With Egfr Exon20 Insertions Mutations in London Advanced Cancers With Egfr Exon20 Insertions Mutations in Halifax Advanced Cancers With Egfr Exon20 Insertions Mutations in New York Advanced Cancers With Egfr Exon20 Insertions Mutations in Los Angeles Advanced Cancers With Egfr Exon20 Insertions Mutations in Chicago Advanced Cancers With Egfr Exon20 Insertions Mutations in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease